Kilitch Drugs (India) Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 16.08 Cr
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 113.65 Cr
- Satisfied Charges ₹ 171.09 Cr
- Revenue Growth 11.54%
- Profit Growth 49.29%
- Ebitda 73.39%
- Net Worth 10.05%
- Total Assets 8.66%
About Kilitch Drugs (India)
Kilitch Drugs (India) Limited. (KDIL) is a leading Public Limited Indian Non-Government Company incorporated in India on 12 May 1992 and has a history of 32 years and 11 months. Its registered office is in Thane, Maharashtra.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524500 and on the National Stock Exchange(NSE) under KILITCH.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 16.08 Cr.
The company currently has active open charges totaling ₹113.65 Cr. The company has closed loans amounting to ₹171.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kilitch Drugs (India) Limited. India are Sunil Jain as CFO and Pushpa Nyoupane as Company Secretary. Venkita Rajan, Mukund Mehta, Bhavin Mehta, and Four other members serve as directors at the Company.
Company Details
- Location Thane, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
Pharma
What products or services does Kilitch Drugs (India) Limited. offer?
Kilitch Drugs (India) Limited. offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Common Disease Medicines, Cough Syrup, Nutraceuticals & Dietary Supplements, Vitamin & Multivitamin Injections, Dyes & Color Additives, Cobaltous Nitrate, Anti Cancer Medicines, Oncology Drug.
Kilitch Drugs (India) Limited.
Explore comprehensive data for Kilitch Drugs (India) Limited., including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Kilitch Drugs (India)?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukund Mehta  | Managing Director | 12-May-1992 | Current |
| Mira Mehta | Managing Director | 30-Sep-2014 | Current |
| Sunil Jain | CFO | 01-Mar-2021 | Current |
| Pushpa Nyoupane | Company Secretary | 05-May-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemang Engineer | Director | 01-Apr-2015 | Current |
| Venkita Rajan | Director | 28-Jun-2018 | Current |
| Bhavin Mehta | Whole-Time Director | 29-Sep-2007 | Current |
| Vasudev Krishnamurti | Director | 16-Mar-2018 | Current |
| Dipen Jain | Director | 27-Aug-2024 | Current |
Financial Performance of Kilitch Drugs (India).
Kilitch Drugs (India) Limited., for the financial year ended 2023, experienced significant growth in revenue, with a 11.54% increase. The company also saw a substantial improvement in profitability, with a 49.29% increase in profit. The company's net worth Soared by an impressive increase of 10.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kilitch Drugs (India)?
In 2022, Kilitch Drugs (India) had a promoter holding of 68.24% and a public holding of 31.75%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Marsap Services Private LimitedVenkita Rajan is a mutual person
- Kilitch Company (Pharma) Limited
Mukund Mehta, Bhavin Mehta and 1 more are mutual person
Sunjewels Private LimitedVasudev Krishnamurti is a mutual person
Polmann India LimitedVasudev Krishnamurti is a mutual person
Anamed Instruments Pvt LtdVenkita Rajan is a mutual person
- Indo Ethiopian Chamber Of Commerce And Industry
Venkita Rajan and Mukund Mehta are mutual person
Charges (Loans)
Open Charges
₹113.65 Cr
Satisfied Charges
₹171.09 Cr
Charges Breakdown by Lending Institutions
- Standard Chartered Bank : 38.25 Cr
- Others : 37.90 Cr
- Hdfc Bank Limited : 37.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | Standard Chartered Bank | ₹37.50 Cr | Open |
| 21 Oct 2023 | Hdfc Bank Limited | ₹37.50 Cr | Open |
| 03 Oct 2022 | Standard Chartered Bank | ₹7.50 M | Open |
| 03 Aug 2020 | Others | ₹2.90 Cr | Open |
| 29 Apr 2015 | Others | ₹35.00 Cr | Open |
How Many Employees Work at Kilitch Drugs (India)?
Kilitch Drugs (India) has a workforce of 152 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kilitch Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kilitch Drugs (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Kilitch Drugs (India)
Recent activity within the organization
- Charges
A charge with Standard Chartered Bank of Rs. 37.50 Cr registered on 21 Nov 2023 with Charge ID 100821297 was modified on 21 Dec 2024.
- Charges
A charge with Hdfc Bank Limited of Rs. 37.50 Cr registered on 21 Oct 2023 with Charge ID 100825253 was modified on 17 Oct 2024.
- Charges
A charge with Others of Rs. 35.00 Cr registered on 29 Apr 2015 with Charge ID 10579714 was modified on 17 Oct 2024.
- Annual General Meeting
Kilitch Drugs (India) Limited. last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
- Director Appointment
Dipen Jayantilal Jain was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 7 months 17 days .
- Balance Sheet
Kilitch Drugs (India) Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Recent News, Updates & Announcement
- Another eye drop recall pulls 28 products off of CVS, Rite Aid, Target and Walmart shelves after FDA warning.
Kilitch Healthcare India is recalling the products more than three weeks after the FDA warned against their use..
Frequently asked questions
What is the Incorporation or founding date of Kilitch Drugs (India) Limited.?
Kilitch Drugs (India) Limited. was incorporated on 12 May 1992.
What is authorized share capital and paid-up capital of Kilitch Drugs (India) Limited.?
The authorized share capital of Kilitch Drugs (India) Limited. is ₹ 25.00 Cr and paid-up capital is ₹ 16.08 Cr.
Who are the current board members & directors of Kilitch Drugs (India) Limited.?
Currently 9 directors are associated with Kilitch Drugs (India) Limited..
- Venkita Subramanian Rajan
- Mukund Prataprai Mehta
- Bhavin Mukund Mehta
- Vasudev Krishnamurti
- Dipen Jayantilal Jain
- Mira Bhavin Mehta
- Hemang Jagadish Engineer
- Sunil Sureshji Jain
- Pushpa Nyoupane
What is the registered address of Kilitch Drugs (India) Limited.?
As per Ministry of Corporate Affairs (Mca), the registered address of Kilitch Drugs (India) Limited. is C 301/2 Midc Ttc Indl Area Pawane India, Thane, Maharashtra, 400705.
What is the corporate identification number (CIN) and company number of Kilitch Drugs (India) Limited.?
The corporate identification number (CIN) of Kilitch Drugs (India) Limited. is L24239MH1992PLC066718 and the company number is 066718 as per Ministry of Corporate Affairs (MCA).
Is Kilitch Drugs (India) Limited. registered with any stock exchange in India?
Yes, Kilitch Drugs (India) Limited. is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): KILITCH.
What is the official website of Kilitch Drugs (India) Limited.?
The Official website of Kilitch Drugs (India) Limited. is https://www.kilitch.com
What has been the recent revenue trend for Kilitch Drugs (India) Limited.?
According to the financial reports for the fiscal year 2023, the revenue trend for Kilitch Drugs (India) Limited. has risen by 11.54%.
How many employees does Kilitch Drugs (India) Limited. currently have?
As Per 2023 financial reports, 152 employees are currently employed by Kilitch Drugs (India) Limited..
What change has been observed in the net worth of Kilitch Drugs (India) Limited., and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Kilitch Drugs (India) Limited. has experienced an upsurge of 10.05%.
What are the total open charges for Kilitch Drugs (India) Limited.?
As per the financial statements for fiscal Year 2023, The total open charges for Kilitch Drugs (India) Limited. amount to ₹ 113.65 Cr.
When was the last Balance Sheet of Kilitch Drugs (India) Limited. filed with the ROC?
The most recent Balance Sheet for Kilitch Drugs (India) Limited. was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Paresh MehtaWholetime Director
Deepak ShenoyDirectorPM
Pramod MehendaleAdditional DirectorPM
Pratap MehtaDirectorNW
Nilima WaingankarDirectorDS
Dinesh ShahDirectorMS
Mukesh ShahDirectorMV
Mahalingam VasudevanDirector
Similar Companies Based on Drug Formulation & Development
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharma Laboratories Limited Vadodara, Gujarat, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Lupin Limited Mumbai, Maharashtra, India
Alkem Laboratories Limited Mumbai, Maharashtra, India
Hetero Labs Limited Rangareddy, Telangana, India
Aurobindo Pharma Ltd Hyderabad, Telangana, India
Cipla Limited Mumbai, Maharashtra, India